The rabies virus (RABV) is an enveloped RNA virus. It mainly damages the central nervous system and causes anencephaly in mammals and humans. There is now compelling evidence that enveloped virions released from infected cells can carry many host proteins, some of which may play an important part in viral replication. Several host proteins have been reported to be incorporated into RABV particles. However, a systematic study to reveal the proteomics of RABV particles has not been conducted. In the present study, after virus culture and purification by sucrose density gradient ultracentrifugation, a proteomics approach was used to analyze the protein composition of purified RABV particles to understand the molecular mechanisms of virus-cell interactions. Fifty host proteins, along with five virus-encoded structural proteins, were identified in purified RABV particles. These proteins could be classified into ten categories according to function: intracellular trafficking (14%), molecular chaperone (12%), cytoskeletal (24%), signal transduction (8%), transcription regulation (12%), calcium ion-binding (6%), enzyme binding (6%), metabolic process (2%), ubiquitin (2%) and other (14%). Of these, four proteins (beta-actin, p-tubulin, Cofilin, Hsc70) were validated by western blotting to be present in purified RABV particles. This novel study of the composition of host proteins in RABV particles may aid investigation of the mechanism of RABV replication.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
RABV antigenic peptide loaded polymeric nanoparticle production, characterization, and preliminary investigation of its biological activity.
Nanotechnology
October 2024
Faculty of Chemical and Metallurgical Engineering, Bioengineering Department, Yildiz Technical University, Istanbul, Turkey.
Nanoparticle-based antigen carrier systems have become a significant area of research with the advancement of nanotechnology. Biodegradable polymers have emerged as particularly promising carrier vehicles due to their ability to address the limitations of existing vaccine systems. In this study, we successfully encapsulated the G5-24 linear peptide, located between amino acids 253 and 275 in the primary sequence of the rabies virus G protein, into biodegradable and biocompatible PLGA copolymer using the double emulsion solvent evaporation method.
View Article and Find Full Text PDFSelf-assembling nanoparticle engineered from the ferritinophagy complex as a rabies virus vaccine candidate.
Nat Commun
October 2024
State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Nankai University, Tianjin, PR China.
Article Synopsis
- There is increasing interest in ferritin-based vaccines as they show better immune response and safety, with some entering phase I trials but facing challenges like variability and assembly issues.
- Researchers created a new delivery system using insights from the human ferritinophagy complex to improve vaccine development.
- They developed a rabies vaccine that effectively binds with the enhanced delivery system, showing strong immune responses and protection in mice, indicating the broad potential of this approach for other vaccines.
Structural Heterogeneity of the Rabies Virus Virion.
Viruses
September 2024
Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles (UCLA), Los Angeles, CA 90095-1489, USA.
Article Synopsis
- The rabies virus (RABV) has historical importance in public health and vaccine development, but its 3D structure has been unclear due to difficulties in isolating consistent samples.
- Researchers utilized advanced techniques like cryogenic electron tomography and microscopy to determine the RABV virion's 3D structure, revealing structural diversity among its bullet-shaped particles.
- The study found that the interaction between nucleoprotein (N) and matrix protein (M) in RABV differs from that in a related virus (VSV), affecting the flexibility of the N-RNA helix and suggesting distinct viral assembly mechanisms.
A single dose of an ALVAC vector-based RABV virus-like particle candidate vaccine induces a potent immune response in mice, cats and dogs.
Emerg Microbes Infect
December 2024
College of Veterinary Medicine, Jilin agricultural University, Changchun, People's Republic of China.
Article Synopsis
- * Researchers have developed a new vaccine candidate called ALVAC-RABV-VLP using CRISPR technology, which shows promise in simplifying immunization and reducing costs.
- * In studies, a single dose of ALVAC-RABV-VLP provided strong immune responses and 100% survival rates in mice exposed to rabies, and it also produced better antibody responses in dogs and cats compared to current vaccines.
A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice.
Emerg Microbes Infect
December 2024
National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, People's Republic of China.
Article Synopsis
- * Researchers created various nucleoside-modified RABV mRNA vaccines that encode different versions of the G protein and include virus-like particles (VLPs) by co-expressing RABV components to enhance immune response.
- * The newly developed RABV mRNA vaccines, particularly the VLP and VLP/N variants, significantly outperformed traditional inactivated rabies vaccines by inducing stronger and longer-lasting immune responses, providing complete protection in mice.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!